Financing - February 17, 2025
AlzeCure receives EU grant for Phase 2 clinical trial
AlzeCure Pharma's project NeuroRestore ACD856 has received EUR 2.5 million from the EU's European Innovation Council.
Financing - January 20, 2025
Gesynta Pharma raises SEK 304 million
Gesynta Pharma has secured SEK 304 million in a Series B financing round led by Innovestor Life Science.
Financing - January 9, 2025
AnaCardio raises USD 19 million
AnaCardio has announced the completion of a USD 19 million Series A extension financing round, co-led by Novo Holdings, Pureos Bioventures and Sound Bioventures. Current investors Flerie, Industrifonden, and Fredrik and Ann-Helene Ljungström, also participated to complete the round.
Biotech Business - December 3, 2024
Alligator announces cost reduction program
Alligator Bioscience is sharpening its primary focus on its lead asset mitazalimab, and, given current capital restraints, plans to adjust the size of its organization and scope of operations to reflect that.
Biotech Business - November 20, 2024
Xbrane enters global licensing agreement with Intas
Xbrane Biopharma and Intas Pharmaceuticals have announced an exclusive global licensing and co-development agreement for Xbrane´s Nivolumab Biosimilar candidate (referencing Opdivo).
Financing - November 12, 2024
SciBase decides on a directed issue and a rights issue
The Board of Directors of SciBase has decided to carry out a capital raise totaling approximately SEK 81.8 million.
